Leaflet IVHEBEX 5000UI/100ml 50UI / ml powder+solvent for solution for infusion


Indicated for: chronic hepatitis B

Route of administration: infusion

Substance: hepatitis B immunoglobulin (immunoglobulin)

ATC: J06BB04 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Hepatitis B immunoglobulin is a medication used to prevent hepatitis B virus (HBV) infection in individuals exposed to the virus, such as newborns of infected mothers or individuals with accidental exposure. It contains antibodies that neutralize the virus, providing immediate protection.

The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing HBV infection when given promptly after exposure.

Side effects may include pain at the injection site, fever, fatigue, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with hepatitis B immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.

General data about IVHEBEX 5000UI/100ml 50UI / ml

  • Substance: hepatitis B immunoglobulin
  • Date of last drug list: 01-01-2019
  • Commercial code: W41749001
  • Concentration: 50UI / ml
  • Pharmaceutical form: powder+solvent for solution for infusion
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LFB - BIOMEDICAMENTS - FRANTA
  • Holder: LFB - BIOMEDICAMENTS - FRANTA
  • Number: 5129/2012/01
  • Shelf life: 3 years-after packing for marketing;after reconstitution-se utlilizeaza imediat